COMP <GO>
EMR vs MSFT // ENTERPRISE SCALE & MARKET CAP
Emerson Electric Company (NYSE) VS. Microsoft Corporation (NASDAQ) • 15-METRIC TALLY: EMR 5
— MSFT 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MSFT
LAST: $164.94 (-3.40%) • MKT CAP: $95.24B
market-cap
$95.24B
LAST: $521.91 (-1.55%) • MKT CAP: $3.88T
market-cap
$3.88T
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. MSFT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | MSFT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.80% | 67.66% | -14.86 | MSFT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 26.54% | -16.84 | MSFT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 30.9x | 19.9x | +10.97 | MSFT | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 1.55% | +1.25 | EMR | /fcf-yield <GO> |
| Operating Margin | 15.50% | 47.10% | -31.60 | MSFT | /operating-margins <GO> |
| Net Profit Margin | 12.70% | 41.17% | -28.47 | MSFT | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | 17.91% | -14.91 | MSFT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.25% | 0.70% | +0.55 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.80 | 9.35 | -4.55 | MSFT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | EMR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.10% | 5.74% | +2.36 | MSFT | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.5 | 49.0 | +7.49 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.14 | +0.20 | EMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | 24.2x | +14.41 | MSFT | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $95.24B | $3.88T | -$3.78T | MSFT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | MSFT REV | EMR GROSS % | MSFT GROSS % | EMR FCF | MSFT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $331.84B | — | 67.9% | — | $66.99B |
| FY 2025 | $18.02B | $281.72B | 52.8% | 68.8% | $2.67B | $71.61B |
| FY 2024 | $17.49B | $245.12B | 50.8% | 69.8% | $2.91B | $74.07B |
| FY 2023 | $15.16B | $211.91B | 44.0% | 68.9% | -$45.4M | $59.48B |
| FY 2022 | — | $198.27B | — | 68.4% | — | $65.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
MSFT // BETA 1.14